Patent: 10,150,967
✉ Email this page to a colleague
Summary for Patent: 10,150,967
| Title: | MicroRNA compounds and methods for modulating miR-122 |
| Abstract: | Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions. |
| Inventor(s): | Bhat Balkrishen, Hogan Daniel |
| Assignee: | Regulus Therapeutics Inc. |
| Application Number: | US15403672 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,150,967
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Hoffmann-la Roche Inc. | ROFERON-A | interferon alfa-2a | For Injection | 103145 | June 04, 1986 | ⤷ Start Trial | 2037-01-11 |
| Kadmon Pharmaceuticals Llc | INFERGEN | interferon alfacon-1 | Injection | 103663 | October 06, 1997 | ⤷ Start Trial | 2037-01-11 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
